Author

Elisabeth Lazaridou

Observed name: Lazaridou, Elisabeth

Institutions: Aristotle University of Thessaloniki, Papageorgiou General Hospital

Observed institutions: Aristotle University of Thessaloniki, Papageorgiou General Hospital

OpenAlex ID: A5138199262

Dermatologic adverse events associated with amivantamab: A multicentre study

2026 · Vasiliki Nikolaou, Ander Mayor, et al. · Journal of the European Academy of Dermatology and Venereology · 6

Clinical features, treatment outcomes, and immunologic profile of immune checkpoint inhibitor–associated bullous pemphigoid: A retrospective multicenter cohort study

2026 · Vasiliki Nikolaou, Ioannis-Alexios Koumprentziotis, et al. · Journal of the American Academy of Dermatology · 1

Real-World Safety of Upadacitinib in Adults and Adolescents With Atopic Dermatitis: 12-Month Analysis of the Multicountry Observational AD-VISE Study

2026 · Charles Lynde, Ahmed Ameen, et al. · SKIN The Journal of Cutaneous Medicine

Response to Zou et al, “Comment on “Clinical features, treatment outcomes, and immunologic profile of immune checkpoint inhibitor–associated bullous pemphigoid: A retrospective multicenter cohort study””

2026 · Vasiliki Nikolaou, Ioannis-Alexios Koumprentziotis, et al. · Journal of the American Academy of Dermatology

Altered distribution and expression of Syndecan-1 and/or-4 as an additional hallmark in psoriasis and target for treatment

2022 · Koliakou, Eleni, Eleni, Manthou Maria, et al. · HAL

Works count: 5

Citation count: 7

H-index: 1

I10-index: